Creative Medical Receives Notice Of Allowance From USPTO For US Patent Application Titled Suppression Of Diabetes Using Exosomes From Stem Cell Programmed Myeloid Cells
Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) ("Creative Medical" or the "Company"), a clinical-stage biotechnology company advancing regenerative medicine solutions, today announced that it
Creative Medical got approval from the government to own a special invention about using stem cells to help with diabetes. This shows the company is making progress on new ideas, so it's worth watching how their medicine testing goes in real life.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.